The
human
gut
microbiome
plays
a
crucial
role
in
regulating
intestinal
and
systemic
health,
impacting
host
immune
response
metabolic
function.
Dysbiosis
of
the
is
linked
to
various
diseases,
including
steatotic
liver
diseases.
Metabolic
dysfunction‐associated
disease
(MASLD),
chronic
characterized
by
excess
hepatic
lipid
content
impaired
metabolism,
leading
cause
worldwide.
Among
microbes,
Ruminococcus
gnavus
(
R.
)
has
garnered
attention
for
its
association
with
inflammatory
While
abundance
correlates
fat
accumulation,
further
research
needed
identify
causal
or
therapeutic
intervention
disease.
This
review
surveys
our
current
understanding
development
progression
highlighting
potential
mechanisms
through
metabolite
secretion,
emphasizes
need
comprehensive
analyses
longitudinal
studies
better
understand
gnavus'
impact
on
health.
knowledge
could
pave
way
targeted
interventions
aimed
at
modulating
microbiota
treat
prevent
MASLD
comorbidities.
Lipids in Health and Disease,
Год журнала:
2024,
Номер
23(1)
Опубликована: Апрель 22, 2024
Abstract
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
has
garnered
considerable
attention
globally.
Changing
lifestyles,
over-nutrition,
and
physical
inactivity
have
promoted
its
development.
MASLD
is
typically
accompanied
by
obesity
strongly
linked
to
metabolic
syndromes.
Given
that
prevalence
on
the
rise,
there
an
urgent
need
elucidate
pathogenesis.
Hepatic
lipid
accumulation
generally
triggers
lipotoxicity
induces
or
progress
steatohepatitis
(MASH)
mediating
endoplasmic
reticulum
stress,
oxidative
organelle
dysfunction,
ferroptosis.
Recently,
significant
been
directed
towards
exploring
role
of
gut
microbial
dysbiosis
in
development
MASLD,
offering
a
novel
therapeutic
target
for
MASLD.
Considering
are
no
recognized
pharmacological
therapies
due
diversity
mechanisms
involved
difficulty
associated
with
undertaking
clinical
trials,
potential
targets
remain
elusive.
Thus,
this
article
aimed
summarize
evaluate
prominent
roles
lipotoxicity,
ferroptosis,
microbes
underlying
their
effects.
Furthermore,
existing
advances
challenges
treatment
were
outlined.
Frontiers in Gastroenterology,
Год журнала:
2025,
Номер
3
Опубликована: Янв. 14, 2025
Non-alcoholic
fatty
liver
disease
(NAFLD)
has
a
rapidly
growing
incidence
worldwide,
affecting
approximately
one-third
of
world
population.
The
disturbance
gut
commensal
bacteria
impacting
host’s
homeostasis
is
referred
to
as
dysbiosis.
microbiome
contributes
the
pathogenesis
NAFLD
through
various
pathways.
Gut
microbiota
at
constant
interactions
with
intestinal
epithelial
barrier
and
affects
its
integrity.
Through
gut-liver
axis,
may
influence
immune
function.
release
lipopolysaccharides
(LPS)
from
intestines
portal
vein
which
are
transported
liver,
trigger
hepatic
inflammation,
steatosis
even
fibrosis.
Moreover,
induces
conversion
primary
bile
acids
(BAs)
secondary
BAs,
activates
receptors,
such
FXR
TGR5.
activation
decreases
fat
absorption
thus
reduces
lipid
accumulation,
while
TGR5
promotes
glucagon-like
peptide-1
(GLP-1)
in
blood.
Furthermore,
ethanol-producing
been
implicated
development.
Additionally,
there
reduction
levels
short-chain
acids,
butyrate,
propionate
acetate.
Many
bacterial
alterations
have
observed
NAFLD,
including
increased
Bacteroidetes
decreased
Firmicutes
.
probiotics
tried
prevention
management,
plethora
strains
Lactobacilli
,
Bifidobacteria
Streptococcus
some
them
promising
perspectives.
There
also
data
administration
prebiotics
(such
inulin
fructo-oligosaccharides)
symbiotics
(probiotics
plus
prebiotics).
Faecal
transplantation
(FMT)
yet
be
evaluated
for
efficacy
against
NAFLD.
Molecular Oral Microbiology,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 27, 2025
ABSTRACT
Streptococcus
mutans
,
the
principal
pathogen
associated
with
dental
caries,
impacts
individuals
across
all
age
groups
and
geographic
regions.
Beyond
its
role
in
compromising
oral
health,
a
growing
body
of
research
has
established
link
between
S.
various
systemic
diseases,
including
immunoglobulin
A
nephropathy
(IgAN),
nonalcoholic
steatohepatitis
(NASH),
infective
endocarditis
(IE),
ulcerative
colitis
(UC),
cerebral
hemorrhage,
tumors.
The
pathogenic
mechanisms
frequently
involve
collagen‐binding
proteins
(CBPs)
protein
antigens
(PA)
present
on
bacterial
surface.
These
components
facilitate
intricate
interactions
host
immune
system,
thereby
potentially
contributing
to
pathological
processes.
Specifically,
CBP
is
implicated
deposition
IgA
complement
component
C3,
which
exhibits
characteristics
reminiscent
IgAN‐like
lesions
through
animal
models,
recent
clinical
studies
suggest
potential
involvement
IgAN.
In
addition,
binds
C1q,
effectively
inhibiting
classical
activation
pathway
system.
promotes
induction
cells
produce
interferon‐gamma
(IFN‐γ).
Furthermore,
leads
direct
inhibitory
effects
platelets
matrix
metalloproteinase‐9
(MMP‐9)
at
sites
vascular
injury.
Moreover,
PA
enhances
ability
invade
hepatic
tissue.
Through
utilization
PAc,
excessively
produces
kynurenine
(KYNA),
development
progression
squamous
cell
carcinoma
(OSCC).
This
article
synthesizes
latest
advancements
understanding
conditions
humans,
expanding
our
perspective
beyond
traditional
focus
caries.
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(7), С. 2882 - 2882
Опубликована: Март 22, 2025
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
is
a
condition
wherein
excessive
fat
accumulates
in
the
liver,
leading
to
inflammation
and
potential
damage.
In
this
narrative
review,
we
evaluate
tissue
microbiota,
how
they
arise
their
constituent
microbes,
role
of
intestinal
hepatic
microbiota
MASLD.
The
history
bacteriophages
(phages)
occurrence
part
causation
MASLD,
conversely,
"phage
therapy"
for
antibiotic
resistance,
obesity,
are
all
described.
metabolism
bile
acids
dietary
tryptophan
histidine
defined,
together
with
impacts
individual
metabolites
on
MASLD
pathogenesis.
Both
periodontitis
dysbiosis
may
cause
microorganisms
involved
these
processes
discussed.
Novel
treatment
opportunities
involving
exist
include
fecal
transplantation,
probiotics,
prebiotics,
synbiotics,
supplements,
intermittent
fasting,
phages
or
holins
endolysins.
Although
FDA
yet
approve
phage
therapy
clinical
use,
there
multiple
FDA-approved
trials,
represent
new
horizon
future
Frontiers in Nutrition,
Год журнала:
2025,
Номер
12
Опубликована: Апрель 10, 2025
To
explore
the
correlation
of
dietary
index
for
gut
microbiota
(DI-GM)
with
non-alcoholic
fatty
liver
disease
(NAFLD).
Data
6,711
participants
were
extracted
from
National
Health
and
Nutrition
Examination
Survey
(NHANES)
during
2007-2018.
A
weighted
logistic
regression
analysis
was
employed
assessment
DI-GM
NAFLD,
a
restricted
cubic
spline
(RCS)
implemented
to
examine
potential
non-linear
associations.
Subgroup
analyses
conducted
identify
particularly
susceptible
groups.
Additionally,
synergistic
effects
different
components
on
NAFLD
risk
assessed
by
quantile
sum
(WQS)
regression.
The
exhibited
statistically
significant
[OR
(95%CI):0.91
(0.85,
0.98),
p
=
0.015].
results
RCS
indicated
linear
(p
0.810
non-linearity).
Further
stratified
that
negative
consistent
all
subgroups.
WQS
revealed
soybean
(27%),
refined
grains
(17%),
coffee
(16%),
red
meat
(9%)
had
highest
contribution
weights
NAFLD.
As
an
important
tool
influences
diet
microbiota,
is
negatively
correlated
factors.
Soybean,
grains,
coffee,
are
key
factors
influencing
direct
shall
be
explored
effectiveness
prevention
treatment
evaluated
improving
scores
via
interventions.